Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab
Reference: ES1 Type: Evidence summary Published: 4 November 2016 Issued by: National Institute for Health and Care Excellence (NICE) Full
Read more
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Pharmacy Guide
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Archives
Refractory extrapulmonary sarcoidosis: infliximab
Reference: ES4 Type: Evidence summary Published: 17 January 2017 Issued by: National Institute for Health and Care Excellence (NICE) Full
Read morePulmonary sarcoidosis: infliximab
Reference: ES2 Type: Evidence summary Published: 20 December 2016 Issued by: National Institute for Health and Care Excellence (NICE) Full
Read moreHyperhidrosis: oxybutynin
Reference: ES10 Type: Evidence summary Published: 21 March 2017 Issued by: National Institute for Health and Care Excellence (NICE) Full
Read moreNarcolepsy with or without cataplexy in adults: pitolisant
Reference: ES8 Type: Evidence summary Published: 14 March 2017 Issued by: National Institute for Health and Care Excellence (NICE) Full
Read moreSkin involvement in systemic sclerosis: rituximab
Reference: ES7 Type: Evidence summary Published: 7 March 2017 Issued by: National Institute for Health and Care Excellence (NICE) Full
Read moreSevere sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide
Reference: ES5 Type: Evidence summary Published: 14 February 2017 Issued by: National Institute for Health and Care Excellence (NICE) Full
Read moreMitochondrial disorders in children: Co-enzyme Q10
Reference: ES11 Type: Evidence summary Published: 28 March 2017 Issued by: National Institute for Health and Care Excellence (NICE) Full
Read moreOpioid dependence: buprenorphine prolonged-release injection (Buvidal)
Reference: ES19 Type: Evidence summary Published: 14 February 2019 Issued by: National Institute for Health and Care Excellence (NICE) Full
Read moreAntimicrobial prescribing: ceftolozane with tazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia
Reference: ES22 Type: Evidence summary Published: 18 December 2019 Issued by: National Institute for Health and Care Excellence (NICE) Full
Read more